Council for europe portal
Language : en Search
Choose language

Background & Mission CD-P-PH

Background

In 2007, the Council of Europe Committee of Ministers agreed to transfer the activities related to pharmaceutical issues from the Partial Agreement in the Social and Public Health field to the EDQM as of 1 January 2008.

The steering body, the European Committee on Pharmaceuticals and Pharmaceutical Care (CD-P-PH), oversees the work programmes carried out by the relevant Committee of Experts.

More information on the European Committee on Pharmaceuticals and Pharmaceutical Care (CD-P-PH)

Background

In 2007, the Council of Europe Committee of Ministers agreed to transfer the activities related to pharmaceutical issues from the Partial Agreement in the Social and Public Health field to the EDQM as of 1 January 2008.

The steering body, the European Committee on Pharmaceuticals and Pharmaceutical Care (CD-P-PH), oversees the work programmes carried out by the relevant Committee of Experts.

CD-P-PH)

Background

In 2007, the Council of Europe Committee of Ministers agreed to transfer the activities related to pharmaceutical issues from the Partial Agreement in the Social and Public Health field to the EDQM as of 1 January 2008.

The steering body, the European Committee on Pharmaceuticals and Pharmaceutical Care (CD-P-PH), oversees the work programmes carried out by the relevant Committee of Experts.

CD-P-PH)

Background

In 2007, the Council of Europe Committee of Ministers agreed to transfer the activities related to pharmaceutical issues from the Partial Agreement in the Social and Public Health field to the EDQM as of 1 January 2008.

The steering body, the European Committee on Pharmaceuticals and Pharmaceutical Care (CD-P-PH), oversees the work programmes carried out by the relevant Committee of Experts.

 

Mission of the European Committee on Pharmaceuticals and Pharmaceutical Care (CD-P-PH)

Its primary responsibilities, according to the terms of reference adopted by the Committee of Ministers, are as follows:

  • Fulfilling the tasks of the Public Health Committee set out in the Convention on the Elaboration of a European Pharmacopoeia, as amended by Articles 2(a), 3 and 4, of the Protocol European Treaty Series No. 134 and in Resolution Res AP (2007)1 on the classification of medicines as regards their supply;
  • Contributing to improving public healthcare through harmonising provisions and practices related to pharmaceuticals in Europe;
  • Minimising the public health risks posed by counterfeit medicines and similar crimes through multisectorial prevention and risk management strategies and through supporting the elaboration and implementation of relevant national and international legislation;
  • Ensuring and monitoring adequate follow-up of the results of the relevant activities of the Council of Europe and of member states party to the Partial Agreement in the Social and Public Health field.

To view the full terms of reference, click HERE.

The following Committees of Experts are involved in carrying out the activities:

twitter facebook googleplus pinterest linkedin email